Literature DB >> 3084496

Patterns of destruction of mouse neuroblastoma cells by extracellular hydrogen peroxide formed by 6-hydroxydopamine and ascorbate.

Y Zaizen, A Nakagawara, K Ikeda.   

Abstract

The patterns of the cytolytic effects of 6-hydroxydopamine (6-OHDA), with/without ascorbate, on C-1300 and three other cloned mouse neuroblastoma cell lines (N1E-115, NS-20, N-18) were studied in vitro. The sensitivity to 6-OHDA differed and the three cloned cell lines were more sensitive than the wild type C-1300 cell line. Ascorbate synergistically potentiated the cytolytic effect of 6-OHDA to all four cell lines. The 6-OHDA cytotoxicity was eliminated by the addition of exogenous catalase but not by addition of other oxygen free radical scavengers, thereby suggesting that the hydrogen peroxide formed might influence the cells, extracellularly. In addition, the critical time for tumor cell lysis was the first 60 min of the reaction. The cytotoxicity induced by the unmasked cyclophosphamide, 4-hydroperoxycyclophosphamide, was synergistically enhanced in the presence of a nontoxic concentration of 6-OHDA and ascorbate. These data suggest that reactive oxygen intermediates may prove to be a good tool for destroying neuroblastoma cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084496     DOI: 10.1007/bf00400743

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  21 in total

1.  Uptake and binding of dopamine and 6-hydroxydopamine in murine neuroblastoma and fibroblast cells.

Authors:  A Rotman; J W Daly; C R Creveling; X O Breakefield
Journal:  Biochem Pharmacol       Date:  1976-02-15       Impact factor: 5.858

2.  6-Hydroxydopamine sensitivity in mouse neuroblastoma and neuroblastoma x L-cell hybrids.

Authors:  R L Cronemeyer; P E Thuillez; T B Shows; J Morrow
Journal:  Cancer Res       Date:  1974-07       Impact factor: 12.701

3.  Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.

Authors:  R Heikkila; G Cohen
Journal:  Mol Pharmacol       Date:  1972-03       Impact factor: 4.436

4.  Cytolytic effect of 6-hydroxydopamine on neuroblastoma cells.

Authors:  P U Angeletti; R Levi-Montalcini
Journal:  Cancer Res       Date:  1970-12       Impact factor: 12.701

5.  Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro.

Authors:  D G Graham; S M Tiffany; W R Bell; W F Gutknecht
Journal:  Mol Pharmacol       Date:  1978-07       Impact factor: 4.436

6.  Evaluation of methods for determining 6-hydroxydopamine cytotoxicity.

Authors:  E Tiffany-Castiglioni; J R Perez-Polo
Journal:  In Vitro       Date:  1980-07

7.  Participation of active oxygen species in 6-hydroxydopamine toxicity to a human neuroblastoma cell line.

Authors:  E Tiffany-Castiglioni; R P Saneto; P H Proctor; J R Perez-Polo
Journal:  Biochem Pharmacol       Date:  1982-01-15       Impact factor: 5.858

8.  Hydrogen peroxide metabolism in human monocytes during differentiation in vitro.

Authors:  A Nakagawara; C F Nathan; Z A Cohn
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1981-05       Impact factor: 12.701

10.  Selective toxicity of 6-hydroxydopamine and ascorbate for human neuroblastoma in vitro: a model for clearing marrow prior to autologous transplant.

Authors:  C P Reynolds; D A Reynolds; E P Frenkel; R G Smith
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

View more
  1 in total

1.  Proteomic analysis of the vitamin C effect on the doxorubicin cytotoxicity in the MCF-7 breast cancer cell line.

Authors:  Peter Bober; Michal Alexovic; Ivan Talian; Zuzana Tomkova; Zuzana Viscorova; Maria Benckova; Igor Andrasina; Rachele Ciccocioppo; Daniel Petrovic; Mariusz Adamek; Peter Kruzliak; Jan Sabo
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.